FRIEDRICH-ALEXANDER-UNIVERSITAT ERLANGEN NURNBERG - (Coördinator)
Country:
Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation.
Full project pageOrganisations map overview
INSTITUT GUSTAVE ROUSSY
Country:
PRONOXIS AB
Country:
REDOXIS AB
Country:
SWANSEA UNIVERSITY
Country:
UNIVERSITAT ZU LUBECK (UZL)
Country:
UNIVERSITATSKLINIKUM ERLANGEN
Country:
UNIVERSITY OF SURREY
Country: